A pioneering treatment in the field of pulmonary carcinoma therapy is Osimertinib, also known as Tagrisso (trade name).The treatment method for individuals with metastatic non-small cell lung cancer (Non-small Cell Lung Cancer) containing Epidermal Growth Factor Receptor mutations has been revolutionized as a initial treatment by it.A comprehensive overview of osimertinib as a first-line treatment, exploring its mechanism of action, effectiveness, adverse effects, and considerations for its use in clinical practice, is aimed to provide this article.The Epidermal Growth Factor Receptor mutations that are commonly found in Non-small Cell Lung…
